When to Stop Allergy Drops: A Safety Decision Guide

Stop immediately and seek emergency care if you develop systemic or severe symptoms after a dose: difficulty breathing or wheezing, tightness or swelling in the throat, widespread hives or itching beyond the mouth, swelling of the face or lips that is spreading, dizziness, a racing heartbeat, or fainting. These signs of a systemic reaction are exceptionally rare with sublingual drops, occurring in fewer than 0.1% of patients in our program with anaphylaxis estimated at roughly one per 100 million doses, but they are medical emergencies when they occur. Use your prescribed epinephrine auto-injector if instructed and call emergency services. After any such reaction, do not resume the drops until you have spoken with your provider, who will reassess whether and how treatment should continue.

Usually no. Mild mouth, throat, or ear itching is the most common reaction to sublingual immunotherapy and is generally not a reason to stop, because it tends to ease over the first one to two weeks as your body builds tolerance. Stopping for routine local reactions can interrupt the gradual desensitization the treatment relies on. If the itching is persistent, strong, or accompanied by pronounced swelling, contact your provider, who may adjust your dose or build-up pace rather than have you stop altogether. The clear exception is any systemic symptom such as breathing difficulty or widespread hives, which means stop and seek emergency care. For everything short of that, talk to your care team before discontinuing so a normal adjustment reaction is not mistaken for a reason to quit.

Sometimes a temporary pause is appropriate, but this is a decision to make with your provider rather than automatically. Acute illness, particularly anything affecting your breathing, or an asthma flare can change how your body responds and may raise the risk of a reaction, so your care team may advise holding doses until you recover. Mouth sores, significant oral inflammation, or recent dental work can also be reasons to pause briefly, since the drops contact the oral lining. Rather than guessing, contact your provider when you become unwell to ask whether to continue, hold, or how to resume safely. Stopping and restarting on your own without guidance can affect both safety and the consistency the treatment depends on, so a quick check-in is the safer approach.

Sublingual immunotherapy works gradually, and durable benefit generally requires several years of consistent treatment, so stopping too early can mean you do not achieve the lasting symptom relief the therapy is meant to provide. Unlike symptom medications that act day to day, immunotherapy is meant to modify the underlying allergic response over time, and interrupting it before that process matures can leave benefits incomplete or short-lived. This is one reason providers encourage working through mild, normal side effects rather than stopping at the first reaction. If you are considering stopping for any reason other than an emergency, discuss it with your provider first; they can explain what stopping would mean for your results and whether an adjustment might address the issue instead of discontinuation.

Restarting after a break is possible, but how it is done depends on why and how long you stopped, so it should always be guided by your provider rather than resumed on your own. After a short pause for illness, your care team may simply advise when to continue. After a longer gap, they may restart you at a lower dose and rebuild gradually, because tolerance can decline during time off treatment and jumping straight back to a previous dose could raise the risk of a reaction. If you stopped because of a systemic or severe reaction, restarting may not be appropriate at all, or only after careful reassessment. The safe path is to contact your provider before resuming so the restart is matched to your situation.